The nature and extent of glycosylation in Plasmodium falciparum has long be
en controversial. It has been widely believed that O-glycosylation is the m
ajor carbohydrate modification in the intraerythrocytic stage of P. falcipa
rum and that the parasite has no N-glycosylation capacity. Contrary to this
, recent studies have demonstrated that P. falciparum has a low N-glycosyla
tion capability, and O-glycosylation is either absent or present at an extr
emely low level, whereas glycosylphosphatidylinositol (GPI) anchor modifica
tion is common and is the major carbohydrate modification in parasite prote
ins. The GPI anchor moieties are essential for parasite survival. The paras
ite GPI anchors can activate signaling pathways ill host cells, and thereby
induce the expression of inflammatory cytokines, adhesion molecules and in
duced nitric oxide synthase (iNOS). This might cause erythrocyte sequestrat
ion, hypoglycemia, triglyceride lipogenesis and immune dysregulation. Thus,
the parasite GPI anchor structure and biosynthetic pathways are attractive
targets for antimalarial and/or antiparasite drug development, as discusse
d here by Channe Gowda and Eugene Davidson.